Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease
about
Side effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharmacologyDrug-induced compulsive behaviors: exceptions to the ruleVNP: Interactive Visual Network Pharmacology of Diseases, Targets, and DrugsImpaired learning of punishments in Parkinson's disease with and without impulse control disorder.Characterizing and predicting the functional and conformational diversity of seven-transmembrane proteins.The risky business of dopamine agonists in Parkinson disease and impulse control disorders.Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control studyRationale for therapeutic silencing of alpha-synuclein in Parkinson's diseaseImpulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case-control studySeniors with Parkinson's disease: initial medical treatment.Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review.Impulse control disorders in Parkinson's disease: clinical characteristics and implications.Are You Morally Modified?: The Moral Effects of Widely Used Pharmaceuticals.Management of sexual dysfunction in Parkinson's disease.Pathological gambling: prevalence, diagnosis, comorbidity, and intervention in Germany.Bupropion in the treatment of problematic online game play in patients with major depressive disorder.DOPA-sparing strategy in the treatment of young onset Parkinson's diseaseA case of ropinirole-induced compulsive behavior.Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson's Disease?Pramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers.Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis.Publicity and reports of behavioral addictions associated with dopamine agonists.Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment.Dopamine heteroreceptor complexes as therapeutic targets in Parkinson's disease.Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.Dopamine Agonists and Impulse Control Disorders: A Complex Association.Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson diseaseDopamine agonists and pathologic behaviors.A case of sleep masturbation related to dopamine agonist therapy.Psychosis and concurrent impulse control disorder in Parkinson's disease: A review based on a case report.Neuropsychiatric and metabolic aspects of dopaminergic therapy: perspectives from an endocrinologist and a psychiatrist.Impulse-Control Disorders in Parkinson's Disease: A Meta-Analysis and Review of Case-Control Studies.Impulsive and compulsive behaviors in Parkinson's disease
P2860
Q26738349-38DE4BA2-2C46-4E43-8114-86744819967FQ28257001-880F51B2-2905-4585-B91C-ED7A6F62C1FCQ28659025-F55E5A4E-DF2B-4E6B-97AA-965BA88CE146Q30313688-16434BF7-DCC5-4993-9AB3-25F16A0F9496Q30411043-C391BB53-A71E-4B00-9988-ECAF8D6F5236Q30425695-CF3FE093-4812-4D7E-AB1A-4B9248D8DFC0Q33573874-03487243-A263-454D-A652-47E48449E8D0Q33636374-2D85E68D-8EFC-4A2A-9E00-6080220F88AEQ34060288-60791593-87F8-4897-BDE6-EF47FB71A25DQ34508143-EC85DAD4-1B2C-4652-89CE-2FCC24CA285FQ34674778-5D0B9AFD-B57B-45F7-8F33-C50C99D9C34BQ35059774-939124F3-9130-4BBD-9AF7-4A8BB756FD24Q35438719-445855E5-FE76-4B7A-BF31-5F04C9107BB0Q35588404-DFE8E713-8EDC-4953-B37E-D805D66C7E56Q35865289-780DB944-E1CF-4FAA-9F03-C6692DB39B46Q36263460-C67F100A-EC76-4217-9941-F2C052EE94EEQ36570659-E772CD1C-0D53-4B7A-9061-E72394127183Q36643278-DC1024EF-E293-49B4-8EF5-5568166A33B9Q36946063-941D6DB3-A160-434B-BF37-DB74AA4B0862Q37345319-929BBCE9-C134-4C51-975E-53828350180DQ37364568-E83B2F38-CDA2-4068-AF42-A3C80C739C2CQ37661970-7984E040-5833-48CE-92C3-C4FE409DF041Q38211499-13B1CDB5-9B6A-44BD-A665-E4C710A7A25AQ38285126-C3E327E4-90C5-40C2-A678-DC5369AABD50Q38342094-5FAE84FB-92D8-4FFC-98D7-C9B54E16DD3AQ38598331-3C568DEE-8CEB-455F-9346-4F44C778E174Q39473205-EFDE901A-7657-4E7A-AFE6-FA85395113EBQ39620073-55E37DBC-0213-42AA-9CBC-5B2905264EDEQ41875582-C7E0B1C3-C785-48C4-85CB-D9AFD4F4EF0AQ47106246-ECC23479-19A1-41A3-9899-283C4F42F837Q49598291-5AFAAB3E-C981-4F43-AD8D-37E8D5141B25Q55250629-55A6369A-6129-44CA-84D8-C59DD01F866AQ58492844-94164754-C23C-4196-AC0D-C12A02ED03E5
P2860
Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Frequency of new-onset patholo ...... f idiopathic Parkinson disease
@ast
Frequency of new-onset patholo ...... f idiopathic Parkinson disease
@en
Frequency of new-onset patholo ...... f idiopathic Parkinson disease
@nl
type
label
Frequency of new-onset patholo ...... f idiopathic Parkinson disease
@ast
Frequency of new-onset patholo ...... f idiopathic Parkinson disease
@en
Frequency of new-onset patholo ...... f idiopathic Parkinson disease
@nl
prefLabel
Frequency of new-onset patholo ...... f idiopathic Parkinson disease
@ast
Frequency of new-onset patholo ...... f idiopathic Parkinson disease
@en
Frequency of new-onset patholo ...... f idiopathic Parkinson disease
@nl
P2093
P2860
P3181
P1476
Frequency of new-onset patholo ...... f idiopathic Parkinson disease
@en
P2093
J Michael Bostwick
James H Bower
Kathleen A Hecksel
Susanna R Stevens
P2860
P3181
P356
10.1016/S0025-6196(11)60538-7
P4011
9b9dcc517cb4d7ceafa713bbea20e90a60e97ba2
P407
P577
2009-04-01T00:00:00Z